Filing Details

Accession Number:
0000875320-24-000080
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-21 16:43:13
Reporting Period:
2024-02-16
Accepted Time:
2024-02-21 16:43:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789815 Ourania Tatsis C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Reg. & Quality Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-16 4,499 $424.01 63,680 No 4 F Direct
Common Stock Disposition 2024-02-20 3,373 $420.58 60,307 No 4 F Direct
Common Stock Disposition 2024-02-20 480 $420.79 59,827 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.